Pros
Compensation and benefits have been higher than industry standard for many roles. There are some signs they are reducing salaries for newly-posted positions, though. Some of the benefits like the annual shutdown between Christmas and New Year's, which is pretty common, have also been eliminated. Resilience is a chaotic startup, chaos breeds opportunity, and that can be a good fit if you are early in your career. Definitely a good place to get some experience, wear multiple hats, and leverage that experience to go elsewhere. And who knows - if they turn their act around, you might have even more opportunity within the company. Everyone agrees that biopharma needs disruption, which is pretty much Resilience's mission. Virtually no one is cynical about that. It's a shame that they have no actual strategy, because if they did, they would have a passionate workforce.
Cons
Resilience roared onto the scene several years ago, rapidly acquiring sites from larger companies and buying a few smaller ones outright. They built a bloated central organization, burning through cash while focusing a lot on the IT/Digital infrastructure, as well as other functions that are only indirectly related to the actual business of contract biologics development and manufacturing. And therein lies the crux of the problem - Resilience leadership hasn't had their eye on the ball, in so many ways. The waste of investor money in this company could be the subject of a book, or a thesis. Millions of dollars would be dumped into solving invented problems or starting (and rarely finishing) projects that had little business justification. These decisions were typically made by the legions of COVID-era work-from-homers with far too much influence, power, and little oversight. These people did not understand the fundamental business or the crucial needs of the cobbled together sites, many of which had and still have significant operational, compliance, and culture problems. And so recently, Resilience has been downsizing with layoffs, elimination of tech platforms, restructuring, moving or mothballing sites, and other measures. A lot of money was spent to put these things in place, and the level of disruption arising from these cost-cutting measures is hard to overstate. The CEO has said that the company made some bets that didn't pay off. The problem is that they were betting with a blindfold on, and by all indications, they still are. Resilience manages change and risk very poorly and has a short time horizon for its decision making. Business Development pursues projects and makes promises that none of the sites have the capability to actually fulfill. Layoffs obliterate entire site functions, forcing those left to stack hats on hats. Critical business processes are disrupted by the latest tech change without advance communication or planning. Priorities are all emergencies, based on the latest pissed off client, botched schedule, or let-them-eat-cake corporate management decree. People are forced into working long shifts and surprise on-call requests. Unsafe working conditions are allowed to persist. Quality issues fester and compound. The last person in a crucial role quits or gets laid off, there is no succession plan, and things get dropped. On and on chaos. If you are a mid-to-late career individual contributor, especially if you are any kind of subject-matter expert, do not work at Resilience. Any expertise you bring will be overruled by people who have more ego than knowledge. Resilience is an anti-expertise organization that will gaslight you into a crisis of self-faith. If you are a mid-to-late career manager, do not work at Resilience. You will be stuck in an accountability without authority trap. Your performance will be almost entirely judged on factors outside of your control. When you inevitably fail, you will get layered, sidelined, and fired.